IP Library Granted Patent US 10,722,286
Granted Patent B2
US 10,722,286 · App. 14/745,136 · Granted Jul 28, 2020

High-voltage pulse ablation systems and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,722,286
App. No.
14/745,136
Granted
Jul 28, 2020
Kind
B2
Abstract

High-voltage pulses ablation systems and methods are used to ablate tissue and form lesions. A variety of different electrophysiology devices, such as catheters, surgical probes, and clamps, may be used to position one or more electrodes at a target location. Electrodes can be connected to power supply lines and, in some instances, the power to the electrodes can be controlled on an electrode-by-electrode basis. High-voltage pulse sequences provide a total amount of heating that is typically less than that which is observed with thermally-based radiofrequency energy ablation protocols.

Claims (10)

1. A method of administering an ablation treatment to a patient, comprising:

compressing a portion of a target tissue with a bipolar clamp assembly, the clamp assembly comprising a first jaw having a first electrode mechanism and a first face and a second jaw having a second electrode mechanism and a second face;

applying a high voltage pulse regimen to the target tissue with the bipolar clamp ablation assembly where the high voltage pulse regimen causes a dielectric breakdown of a cellular membrane tissue to create a lesion in the target tissue where a depth of the lesion is correlated to the high voltage pulse regimen; and

after applying the high voltage pulse regimen to the tissue, heating the tissue with the bipolar clamp ablation assembly to produce a visible mark to identify the lesion.

2. The method according to claim 1 , wherein the patient tissue comprises a plurality of myocardial cells, and the ablation treatment is sufficient to kill the plurality of myocardial cells between the jaw faces.

3. The method according to claim 1 , wherein the patient tissue comprises a plurality of myocardial cells, and the ablation treatment is sufficient to cause irreversible damage the plurality of myocardial cells.

4. The method according to claim 1 , wherein the portion of patient tissue comprises a strip of tissue between the first jaw face and the second jaw face, and wherein the ablation treatment is sufficient to create a lesion within the strip of tissue, the lesion having a maximum width disposed midway between the first jaw face and the second jaw face.

5. The method according to claim 4 , wherein the first jaw face comprises a first electrode having a width of about 2 mm and the second jaw face comprises a second electrode having a width of about 2 mm, and wherein the maximum width of the lesion is about 10 mm or less.

6. The method according to claim 1 , wherein the first jaw face and the second jaw face are separated by less than about 5 mm.

7. The method according to claim 1 , wherein the high voltage pulse regimen comprises a plurality of 500-1000 volt pulses each having a duration of between about 0.02 msec and about 0.1 msec, and wherein the pulses are delivered at a frequency comprising a pulse number within a range from about 5 to about 50 pulses discharged over a time interval within a range from about 1 to about 60 seconds.

Assignments (6)
MERGER AND CHANGE OF NAME Recorded Jan 28, 2026
From: ENDOSCOPIC TECHNOLOGIES, INC.; NINERS MERGER SUB, LLC
To: ENDOSCOPIC TECHNOLOGIES, LLC
Reel/Frame 073620/0158 →
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2024
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC; SENTREHEART LLC
Reel/Frame 066256/0797 →
SECURITY INTEREST Recorded Jan 10, 2024
From: ATRICURE, INC.; ATRICURE, LLC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066267/0896 →
SECURITY INTEREST Recorded Dec 18, 2018
From: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC
To: SILICON VALLEY BANK
Reel/Frame 047951/0496 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2016
From: ENDOSCOPIC TECHNOLOGIES, LLC
To: ATRICURE, INC.
Reel/Frame 041222/0218 →
SECOND AMENDED AND RESTATED JOINT INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 25, 2016
From: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC
To: SILICON VALLEY BANK
Reel/Frame 038520/0062 →